«Squalenoylation»: A new approach to the design of anticancer and antiviral nanomedicines;La «squalénisation»: Un exemple de conception de nanomédicaments anticancéreux et antiviraux

Bulletin de l'Academie Nationale de Medecine

Volumn 193, Issue 3, 2009, Pages 663-674

  Couvreur, Patrick ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Antineoplastic agents; Antiviral agents; Disease Transmission; Gemcitabine; Nanomedicine; Nanoparticles; Nucleosides; Squalene

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; NANOPARTICLE; SQUALENE;

ARTICLE; DRUG DESIGN; HUMAN; NANOTECHNOLOGY;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; DRUG DESIGN; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; SQUALENE;

EID: 70350347254     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32558-0     Document Type: Article

References (12)

1. OURISSON, G. - Pecularities of sterol biosynthesis in plants. J. Plant Physiology. 1994, 143, 434-439.
2. BLONDIN G.A. et al. The biosynthesis of squalene and sterols in fish.Comparative Biochem and Physiol. 1966, 17, 391-407.
3. COUVREUR P., STELLA B., ROCCO F., ROSILIO V., RENOIR J.M., CATTEL L. - Nanoparticules de dérivés de la gemcitabine. Brevet PCT/FR2005/050488.
4. COUVREUR P, STELLA B, HARIVARDHAN REDDY L, HILLAIREAU H, DUBERNET C, DESMAËLE D, LEPÊTRE-MOUELHI S, ROCCO F, DEREUDDRE-BOSQUET N, CLAYETTE P, ROSILIO V, MARSAUD V, RENOIR M, CATTEL L., Squalenoyl nanomedicines as potential therapeutics Nano Letters. 2006, 6, 2544-2548.
5. COUVREUR P, HARIVARDHAN REDDY L., MANGENOT S, POUPAERT JH., DESMAËLE D, LEPÊTRE-MOUELHI S, PILI B, BOURGAUX C, AMENITSCH H., OLLIVON M. - Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. Small. 2008, 4, 247-253.
6. PLUNKETT W., HUANG P. & GHANDI V. - Preclinical characteristics of gemcitabine. Anticancer Drugs. 1995, 6, 7-13.
7. ABBRUZZESE J. L. et al. - A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J. Clin. Oncol. 1991, 9, 491-498.
8. HARIVARDHAN REDDY L, DUBERNET C, LEPETRE MOUELHI S., DESMAELE D., COUVREUR P. - A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types, J Control Rel. 2007, 124, 20-27.
9. HARIVARDHAN REDDY L., KHOURY H, PACI A, DEROUSSENT A, FERREIRA H, DUBERNET C, DECLÈVES X, BESNARD M, CHACUN H, LEPÊTRE-MOUELHI S, DESMAËLE D, ROUSSEAU B, LAUGIER C, CINTRAT J-C, VASSAL G, COUVREUR P. - Squalenoylation favourably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine, Drug Disposit. Metab. 2008, 36, 1570-1577.
10. HARIVARDHAN REDDY L., MARQUE P-E, DUBERNET C, LEPÊTRE MOUELHI S., DESMAËLE D., COUVREUR P. - Preclinical toxicology (sub-acute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine. J Pharm Exp Therapeut.. 2008, 325, 484-490.
11. HARIVARDHAN REDDY L., FERREIRA H., DUBERNET C, LEPÊTRE-MOUELHI S, DESMAËLE D, ROUSSEAU B., COUVREUR P. - Oral absorption and tissue distribution of a new squalenoyl anticancer nanomedicine. Journal of Nanoparticle Research. 2008, 10, 887-891.
12. BEKKARA-AOUNALLAH F., GREF R., OTHMAN M., HARIVARDHAN REDDY L., PILI B., ALLAIN V., BOURGAUX C., HILLAIREAU H., LEPÊTRE-MOUELHI S., DESMAËLE D., NICOLAS J., CHAFI N., COUVREUR P . - Novel PEGylated nanoassemblies made of self-assembled squalenoyl nucleoside analogues. Adv. Funct. Mater. 2008. Sous presse.